Bronchitis, Chronic Clinical Trial
Official title:
AVANTI - Avelox® in Acute Exacerbations of Chronic Bronchitis
The objective of this global non-interventional study is to evaluate the impact of Acute
Exacerbation of Chronic Bronchitis(AECB) on the patient and the community as well as the
safety and effect of a treatment with Moxifloxacin tablets in daily life clinical practice.
This includes data on the course of symptom relief, speed of return to normal daily life
activities as well as records on adverse events.
This study will be performed in accordance with international guidelines like EMEA (EMEA,
EUDRALEX Volume 9A, Pharmacovigilance for Medicinal Products for Human Use) as well as local
laws.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00245453 -
Outpatient Registry Trial of Respiratory Tract Infections in Adults
|
Phase 4 | |
| Completed |
NCT00473460 -
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
|
Phase 3 | |
| Completed |
NCT00649831 -
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
|
Phase 3 | |
| Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
| Active, not recruiting |
NCT00608764 -
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
|
||
| Completed |
NCT00538148 -
Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD
|
Phase 4 | |
| Completed |
NCT02637219 -
Innate Immune Response in COPD
|
N/A | |
| Completed |
NCT00406705 -
The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD
|
Phase 2 | |
| Completed |
NCT00257140 -
A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
|
Phase 2/Phase 3 | |
| Completed |
NCT01719822 -
Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
|
N/A | |
| Terminated |
NCT02261350 -
Post-hospitalisation Nutritional Support and Gait Speed in COPD
|
Phase 3 | |
| Completed |
NCT01495780 -
eRT Remote Health Monitoring
|
N/A | |
| Completed |
NCT01077102 -
Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
| Terminated |
NCT00288223 -
Telithromycin in Acute Exacerbation of Chronic Bronchitis
|
Phase 4 | |
| Completed |
NCT00644449 -
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
|
Phase 3 | |
| Completed |
NCT00423137 -
Effect of BIBW 2948 BS in COPD
|
Phase 2 | |
| Completed |
NCT02483637 -
Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients
|
N/A | |
| Completed |
NCT00932802 -
Greatest International Antiinfective Trial With Avelox
|
N/A | |
| Completed |
NCT00245427 -
Outcomes of Patients Not Responding to Antibiotics in the Community
|
N/A | |
| Completed |
NCT00035828 -
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
|
Phase 2 |